Please check your internet connection and try again.
# Arsil DX (Dextromethorphan + Guaifenesin)
## Overview
Arsil DX is a combination product containing dextromethorphan hydrobromide (an antitussive) and guaifenesin (an expectorant). It is indicated for the temporary relief of coughs due to minor throat and bronchial irritation associated with the common cold or inhaled irritants.
## Primary Indications
* Temporary relief of cough.
* Thins and loosens mucus (expectorant) to make coughs more productive.
## Adult Dosing
* **Standard Dose:** 10–20 mg (dextromethorphan) / 200–400 mg (guaifenesin) every 4 hours, or 30 mg / 600 mg every 6-8 hours.
* **Maximum Dose:** Not to exceed 120 mg of dextromethorphan per 24 hours.
## Pediatric Dosing
* **Children 6 to 12 years:** 5–10 mg (dextromethorphan) / 100–200 mg (guaifenesin) every 4 hours. Maximum: 60 mg dextromethorphan per 24 hours.
* **Children 4 to 6 years:** Consult a physician; generally 2.5–5 mg (dextromethorphan) / 50–100 mg (guaifenesin) every 4 hours. Maximum: 30 mg dextromethorphan per 24 hours.
* **Under 4 years:** Generally not recommended unless directed by a pediatrician.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No formal adjustments established, but caution is advised in severe cases due to metabolite accumulation.
* **Geriatric Patients:** Start at the lower end of the dosing range due to potential sensitivity to CNS effects.
## Contraindications
* Known hypersensitivity to dextromethorphan or guaifenesin.
* Current use or use within the past 14 days of Monoamine Oxidase Inhibitors (MAOIs).
* Chronic cough associated with smoking, asthma, chronic bronchitis, or emphysema (unless directed by a physician).
## Adverse Effects
* **Common:** Nausea, vomiting, stomach pain, dizziness, or drowsiness.
* **Serious (Rare):** Serotonin syndrome (if combined with serotonergic agents), or paradoxical CNS excitation or confusion.
## Key Drug Interactions
* **MAOIs:** Risk of serotonin syndrome/hypertensive crisis.
* **CNS Depressants (Alcohol, Sedatives):** Potentiates sedation.
* **SSRIs/SNRIs:** Increased risk of serotonin syndrome.
## Monitoring
* Monitor for efficacy (reduction in cough frequency).
* Monitor for signs of serotonin syndrome (tremor, agitation, tachycardia, diaphoresis).
* Evaluate patients if cough persists for more than 7 days, recurs, or is accompanied by high fever, rash, or persistent headache.
## Clinical Pearls
* Dextromethorphan has potential for abuse; pharmacists should screen for misuse or frequent requests for the product.
* Encourage adequate hydration to assist guaifenesin in thinning bronchial secretions.
* Ensure patients check ingredient labels to avoid "double-dosing" with other multi-symptom cold/flu preparations containing the same components.
***
**Educational Disclaimer:** This information is for educational purposes only. Drug information, dosing guidelines, and contraindications change frequently. Always consult the most recent package insert, official prescribing information, or local clinical protocols before prescribing or administering medication.
